- Home
- ALZN vs GAUZ Comparison
ALZN vs GAUZ Comparison
Compare ALZN & GAUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALZN | GAUZ |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 8.1M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ALZN | GAUZ |
|---|---|---|
| Price | $1.66 | $0.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $28.00 | $11.50 |
| AVG Volume (30 Days) | 69.6K | ★ 11.9M |
| Earning Date | 03-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 76.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $22.59 |
| Revenue Next Year | N/A | $59.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.84 | $0.23 |
| 52 Week High | $2.68 | $7.07 |
Technical Indicators
Market Signals| Indicator | ALZN | GAUZ |
|---|---|---|
| Relative Strength Index (RSI) | 68.02 | 59.22 |
| Support Level | $1.04 | $0.48 |
| Resistance Level | $2.25 | $0.72 |
| Average True Range (ATR) | 0.09 | 0.07 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 100.00 | 90.59 |
Price Performance
Historical ComparisonAbout ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.
About GAUZ Gauzy Ltd. Ordinary Shares
Gauzy Ltd is a fully integrated light and vision control company. Its products products include suspended particle device, or SPD, and liquid crystal, or LC, materials for smart glass applications, and AI-powered advanced driver assistance systems, or ADAS, solutions including camera monitoring systems, or CMS. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries.